1. Home
  2. ADCT vs LESL Comparison

ADCT vs LESL Comparison

Compare ADCT & LESL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADCT
  • LESL
  • Stock Information
  • Founded
  • ADCT 2011
  • LESL 1963
  • Country
  • ADCT Switzerland
  • LESL United States
  • Employees
  • ADCT N/A
  • LESL N/A
  • Industry
  • ADCT Biotechnology: Pharmaceutical Preparations
  • LESL Diversified Commercial Services
  • Sector
  • ADCT Health Care
  • LESL Miscellaneous
  • Exchange
  • ADCT Nasdaq
  • LESL Nasdaq
  • Market Cap
  • ADCT 127.9M
  • LESL 116.5M
  • IPO Year
  • ADCT 2020
  • LESL 2020
  • Fundamental
  • Price
  • ADCT $1.28
  • LESL $0.73
  • Analyst Decision
  • ADCT Strong Buy
  • LESL Hold
  • Analyst Count
  • ADCT 5
  • LESL 11
  • Target Price
  • ADCT $7.75
  • LESL $2.32
  • AVG Volume (30 Days)
  • ADCT 235.3K
  • LESL 2.3M
  • Earning Date
  • ADCT 05-14-2025
  • LESL 05-08-2025
  • Dividend Yield
  • ADCT N/A
  • LESL N/A
  • EPS Growth
  • ADCT N/A
  • LESL N/A
  • EPS
  • ADCT N/A
  • LESL N/A
  • Revenue
  • ADCT $70,837,000.00
  • LESL $1,319,859,000.00
  • Revenue This Year
  • ADCT $6.82
  • LESL $2.77
  • Revenue Next Year
  • ADCT $18.56
  • LESL $2.93
  • P/E Ratio
  • ADCT N/A
  • LESL N/A
  • Revenue Growth
  • ADCT 1.84
  • LESL N/A
  • 52 Week Low
  • ADCT $1.05
  • LESL $0.51
  • 52 Week High
  • ADCT $4.83
  • LESL $6.02
  • Technical
  • Relative Strength Index (RSI)
  • ADCT 43.00
  • LESL 56.70
  • Support Level
  • ADCT $1.23
  • LESL $0.64
  • Resistance Level
  • ADCT $1.49
  • LESL $0.73
  • Average True Range (ATR)
  • ADCT 0.08
  • LESL 0.05
  • MACD
  • ADCT 0.00
  • LESL 0.03
  • Stochastic Oscillator
  • ADCT 25.00
  • LESL 94.11

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

About LESL Leslie's Inc.

Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.

Share on Social Networks: